Compliance Rates, Influential Factors, Industry Implications, and Strategies for Increasing Compliance
This publication provides insight into key hyperlipidemia treatment compliance issues, including compliance rates, factors influencing compliance, industry implications, and strategies for improving compliance. It offers pharmaceutical marketing teams a better understanding of how patients feel about complying with current treatment options, and what they desire in the treatment of hyperlipidemia. Factors related to treatment regimens, patient demographics, disease characteristics, economics, and the patient-provider relationship that influence compliance are also revealed.
Refine Forecasts by Incorporating Noncompliance Rates
- Predict product uptake more accurately using specific rate estimates of hyperlipidemia therapy compliance.
- Use disease- and drug-specific rates to develop more precise forecasts of product utilization by target sub-populations.
- Understand how education efforts can improve patient compliance with hyperlipidemia therapies.
Design and Focus Marketing Efforts Using Insight into Patient Issues
Learn what patients have to say about their reasons for noncompliance with current therapies. Use this information to develop targeted programs based on patients' perceptions and desires; further, leverage it when making critical business strategy decisions, including marketing planning, licensing, and pipeline development.
This Essential Business Intelligence Tool will enable pharmaceutical executives to:
- Improve forecast precision by accounting for noncompliance
- Create targeted patient education and healthcare professional programs
- Develop strategies utilizing multiple approaches for improving compliance
- Design more sophisticated clinical trial protocols by understanding unmeasured errors in patient compliance with medication regimens
- Enhance product development by obtaining information about drugs side effects and formulation issues
This Comprehensive and In-depth Resource on Hyperlipidemia Patient Compliance:
- Provides rates of patient compliance with treatments for hyperlipidemia, or "high cholesterol"
- Reveals the economic costs of patient non-compliance
- Identifies key reasons for patient non-compliance
- Discloses strategies for improving patient compliance with hyperlipidemia treatments
- Incorporates direct patient quotes regarding compliance with hyperlipidemia treatments
- Examines patients' critical desires for improving compliance with hyperlipidemia therapies
- Presents economic and clinical implications for patient noncompliance
View Cart
